116 related articles for article (PubMed ID: 32861350)
1. 64-Year-Old Man With Altered Mental Status.
Schmidt TJ; Subat YW; Gallo De Moraes A
Mayo Clin Proc; 2020 Sep; 95(9):e91-e96. PubMed ID: 32861350
[No Abstract] [Full Text] [Related]
2. Immunotherapy-induced autoimmune hypophysitis.
Valecha G; Pant M; Ibrahim U; Atallah JP
J Oncol Pharm Pract; 2019 Jan; 25(1):217-220. PubMed ID: 28825378
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hypophysitis secondary to therapy with immune checkpoint inhibitors: Four cases describing the clinical heterogeneity of central endocrine dysfunction.
Hartmann A; Paparoupa M; Volkmer BG; Rompel R; Wittig A; Schuppert F
J Oncol Pharm Pract; 2020 Oct; 26(7):1774-1779. PubMed ID: 32164491
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune hypophysitis.
Ileana-Dumbrava E; Subbiah V
Lancet Oncol; 2018 Feb; 19(2):e123. PubMed ID: 29413466
[No Abstract] [Full Text] [Related]
5. Case of metastatic uveal melanoma in which an antitumor effect appeared after ipilimumab discontinuation due to autoimmune hypophysitis.
Ohnuma T; Matsuzawa T; Kinoshita M; Sano S; Kawamura T; Shimada S; Inozume T
J Dermatol; 2017 Nov; 44(11):1325-1326. PubMed ID: 27864834
[No Abstract] [Full Text] [Related]
6. Hypophysitis and other autoimmune complications related to immune checkpoints inhibitors´ treatment: Spectrum of imaging appearances.
Malikova H; Holesta M; Fialova A; Arenbergerova M; Weichet J
Neuro Endocrinol Lett; 2018 Sep; 39(3):196-204. PubMed ID: 30431741
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint inhibitors myocarditis: not all cases are clinically patent.
Thibault C; Vano Y; Soulat G; Mirabel M
Eur Heart J; 2018 Oct; 39(38):3553. PubMed ID: 30107497
[No Abstract] [Full Text] [Related]
8. Review on Recent Topics in Hypophysitis.
Sugihara H
J Nippon Med Sch; 2017; 84(5):201-208. PubMed ID: 29142180
[TBL] [Abstract][Full Text] [Related]
9. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
Sekizaki T; Kameda H; Oba C; Yong Cho K; Nakamura A; Miyoshi H; Osawa T; Shinohara N; Atsumi T
Endocr J; 2019 Oct; 66(10):937-941. PubMed ID: 31217401
[TBL] [Abstract][Full Text] [Related]
10. Ipilimumab-related hypophysitis may precede severe CNS immune attack.
Köessler T; Olivier T; Fertani S; Marinari E; Dutoit V; Dietrich PY
Ann Oncol; 2016 Oct; 27(10):1975-6. PubMed ID: 27358386
[No Abstract] [Full Text] [Related]
11. Ipilimumab-Induced Secondary Hypophysitis.
Cheema A
Endocr Pract; 2018 Sep; 24(9):854. PubMed ID: 29624100
[No Abstract] [Full Text] [Related]
12. Ipilimumab-induced hypophysitis and ileocolitis: Serial pituitary MRI findings.
Singh D; Hsu CC; Kwan GN; Bhuta S
Neurol India; 2017; 65(1):165-166. PubMed ID: 28084260
[No Abstract] [Full Text] [Related]
13. Ipilimumab Induced Hypophysitis: MRI Findings in a Series of 3 Cases.
Wadhwa V
J Ark Med Soc; 2017 May; 113(11):270-272. PubMed ID: 30351740
[TBL] [Abstract][Full Text] [Related]
14. Endocrinopathies Related to Immune Checkpoint Inhibitors.
Khalid M; Aziz SW
Am J Ther; 2019; 26(5):e608-e609. PubMed ID: 29965803
[No Abstract] [Full Text] [Related]
15. Checkpoint Inhibitor-Associated Hypophysitis.
Chang LS; Yialamas MA
J Gen Intern Med; 2018 Jan; 33(1):125-127. PubMed ID: 28770379
[No Abstract] [Full Text] [Related]
16. A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma.
Sakaguchi C; Yano S; Ashida K; Wada N; Ohe K; Nagata H; Matsuda Y; Sakamoto S; Sakamoto R; Ohnaka K; Uchi H; Furue M; Nomura M; Ogawa Y
Am J Case Rep; 2019 Jan; 20():106-110. PubMed ID: 30679413
[TBL] [Abstract][Full Text] [Related]
17. Headache in a patient with renal cell carcinoma.
Subbiah V; Maiti A
Eur J Intern Med; 2016 Jul; 32():e3-4. PubMed ID: 26905772
[No Abstract] [Full Text] [Related]
18. Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.
Tiu C; Pezaro C; Davis ID; Grossmann M; Parente P
Asia Pac J Clin Oncol; 2015 Jun; 11(2):190-4. PubMed ID: 25855890
[TBL] [Abstract][Full Text] [Related]
19. Immune Checkpoint Inhibitor-Associated Central Adrenal Insufficiency.
Mishra T; He G; Sreeram K; Rauf M; Subahi A; Hazem M
Am J Ther; 2019; 26(5):e626-e627. PubMed ID: 30277909
[No Abstract] [Full Text] [Related]
20. Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Motzer RJ; Tannir NM; McDermott DF; Arén Frontera O; Melichar B; Choueiri TK; Plimack ER; Barthélémy P; Porta C; George S; Powles T; Donskov F; Neiman V; Kollmannsberger CK; Salman P; Gurney H; Hawkins R; Ravaud A; Grimm MO; Bracarda S; Barrios CH; Tomita Y; Castellano D; Rini BI; Chen AC; Mekan S; McHenry MB; Wind-Rotolo M; Doan J; Sharma P; Hammers HJ; Escudier B;
N Engl J Med; 2018 Apr; 378(14):1277-1290. PubMed ID: 29562145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]